Nuclear Medicine and Biology
Volume 35, Issue 8 , Pages 875-882 , November 2008

Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals

  • Cara L. Ferreira

      Affiliations

    • MDS Nordion, 4004 Wesbrook Mall, Vancouver, BC, Canada V6T 2A3
    • Corresponding Author InformationCorresponding author. Tel.: +1 604 228 8952; fax: +1 604 228 5590.
    • ,
  • Donald T. Yapp

      Affiliations

    • British Columbia Cancer Agency Research Centre, Vancouver, BC, Canada V5Z 1L3
    • ,
  • Eric Lamsa

      Affiliations

    • MDS Nordion, 4004 Wesbrook Mall, Vancouver, BC, Canada V6T 2A3
    • ,
  • Martin Gleave

      Affiliations

    • Prostrate Centre at Vancouver General Hospital, Vancouver, BC, Canada V6H 3Z6
    • ,
  • Corinne Bensimon

      Affiliations

    • MDS Nordion, 4004 Wesbrook Mall, Vancouver, BC, Canada V6T 2A3
    • ,
  • Paul Jurek

      Affiliations

    • Macrocylics Inc., Dallas, Texas, 75235 USA
    • ,
  • Garry E. Kiefer

      Affiliations

    • Macrocylics Inc., Dallas, Texas, 75235 USA

Received 16 April 2008 ,Revised 25 August 2008 ,Accepted 5 September 2008.

References 

  1. Williams HA, Robinson S, Julyan P, Zweit J, Hastings D. A comparison of PET imaging characteristics of various copper radioisotopes. Eur J Nucl Med Biol. 2005;32:1473–1480
  2. Bryan JN, Jia F, Mohsin H, Sivaguru G, Miller WH, Anderson CJ, et al. Comparative uptakes and biodistribution of internalizing vs. moninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nucl Med Biol. 2005;32:851–858
  3. Li M, Meares CF. Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. Bioconjugate Chem. 1993;4:275–283
  4. Moshin H, Fitzsimmons J, Shelton T, Hoffman TJ, Cutler CS, Lewis MR, et al. Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3. Nucl Med Biol. 2007;34:493–502
  5. Liu S, Pietryka J, Ellars CE, Edwards DS. Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: Models for 90Y- and 111In-labeled DOTA-biomolecule conjugates. Bioconjugate Chem. 2002;13:902–913
  6. Carrasquillo JA, White JD, Paik CH, Raubitschek AN, Rotman M, Brechbiel MW, et al. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution. J Nucl Med. 1999;40:268–276
  7. Cole WC, DeNardo SJ, Meares CF, McCall MJ, DeNardo GL, Epstein AL, et al. Comparative serum stability of radiochelates for antibody radiopharmaceuticals. J Nucl Med. 1987;28:83–90
  8. Cole WC, DeNardo SJ, Meares CF, McCall MJ, DeNardo GL, Epstein AL, et al. Serum stability of 67Cu chelates: comparison with 111In and 57Co. Nucl Med Biol. 1986;13:363–368
  9. Jones-Wilson TM, Deal KA, Anderson CJ, McCarthy DW, Kovacs Z, Motekaitis R, et al. The in vivo behaviour of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol. 1998;25:523–530
  10. De Leon-Rodriguez LM, Kovacs Z. The synthesis and chelation chemistry of DOTA-peptide conjugates. Bioconjugate Chem. 2008;19:391–402
  11. Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, et al. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem. 2004;47:1465–1474
  12. Zhang K, Aruva MR, Shanthly N, Cardi CA, Patel CA, Rattan S, et al. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation. Regul Pept. 2007;144:91–100
  13. Chong HS, Mhaske S, Lin M, Bhuniya S, Song HA, Brechbiel MW, et al. Novel Synthetic ligands for targeted PET imaging and radiotherapy of copper. Bioinorg Med Chem Lett. 2007;17:6107–6110
  14. Prasanphanich AF, Nanda PK, Rold TL, Lixin M, Lewis MR, Garrison JC, et al. [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues. Proc Natl Acad Sci. 2007;104:12462–12467
  15. Sun X, Wuest M, Weisman GR, Wong EH, Reed DP, Boswell CA, et al. Radiolabeling and in vivo behaviour of copper-64-labeled cross-bridged cyclam ligands. J Med Chem. 2002;45:469–477
  16. Sprague JE, Peng Y, Fiamengo AL, Woodin KS, Southwick EA, Weisman GR, et al. Synthesis, characterization and in vivo studies of Cu-(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J Med Chem. 2007;50:2527–2535
  17. Di Bartolo NM, Sargeson AM, Donlevy TM, Smith SV. Synthesis of a new cage ligand, SarAr, and its complexation with selected transition metal ions for potential use in radioimaging. J Chem Soc Dalton Trans. 2001;2303–2309
  18. Delgado R, Sun Y, Motekaitis R, Martell AE. Stabilities of divalent and trivalent metal ion complexes of macrocyclic triazatriacetic acids. Inorg Chem. 1993;32:3320–3326
  19. Costa J, Delgado R. Metal complexes of macrocyclic ligands containing pyridine. Inorg Chem. 1993;32:5257–5265
  20. Tai YC, Ruangma A, Rowland D, Siegel S, Newport DF, Chow PL, et al. Performance evaluation of the microPET focus: a third generation microPET scanner dedicated to animal imaging. J Nucl Med. 2005;46:445–463
  21. Yoo J, Reichert DE, Welch MJ. Comparative in vivo behaviour studies of cyclen-based copper-64 complexes: regioselective synthesis, x-ray structure, radiochemistry, log P, and biodistribution. J Med Chem. 2004;47:6625–6637

PII: S0969-8051(08)00180-7

doi: 10.1016/j.nucmedbio.2008.09.001

Nuclear Medicine and Biology
Volume 35, Issue 8 , Pages 875-882 , November 2008

Article Tools

* Image Usage & Resolution